Susquehanna International Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-62,963
| Closed | -$3.25M | – | 14595 |
|
|
2022
Q3 | $3.25M | Sell |
62,963
-91,188
| -59% | -$3.77M | ﹤0.01% | 3918 |
|
|
2022
Q2 | $3.82M | Sell |
154,151
-18,198
| -11% | -$401K | ﹤0.01% | 3650 |
|
|
2022
Q1 | $4.32M | Sell |
172,349
-109,697
| -39% | -$3.08M | ﹤0.01% | 3885 |
|
|
2021
Q4 | $10.3M | Sell |
282,046
-59,028
| -17% | -$2.07M | ﹤0.01% | 2680 |
|
|
2021
Q3 | $5.83M | Sell |
341,074
-77,396
| -18% | -$1.21M | ﹤0.01% | 3684 |
|
|
2021
Q2 | $5.6M | Buy |
418,470
+407,847
| +3,839% | +$10M | ﹤0.01% | 3834 |
|
|
2021
Q1 | $544K | Sell |
10,623
-92
| -0.9% | -$5.54K | ﹤0.01% | 9272 |
|
|
2020
Q4 | $663K | Sell |
10,715
-10,972
| -51% | -$628K | ﹤0.01% | 7662 |
|
|
2020
Q3 | $1.19M | Sell |
21,687
-212,781
| -91% | -$11.5M | ﹤0.01% | 5702 |
|
|
2020
Q2 | $13.5M | Buy |
234,468
+21,849
| +10% | +$1.19M | ﹤0.01% | 1811 |
|
|
2020
Q1 | $8.54M | Buy |
212,619
+124,446
| +141% | +$5.28M | ﹤0.01% | 1920 |
|
|
2019
Q4 | $3.49M | Sell |
88,173
-178,921
| -67% | -$3.14M | ﹤0.01% | 3470 |
|
|
2019
Q3 | $1.81M | Buy |
267,094
+219,729
| +464% | +$1.65M | ﹤0.01% | 4412 |
|
|
2019
Q2 | $440K | Buy |
+47,365
| New | +$548K | ﹤0.01% | 7536 |
|
|
2019
Q1 | – | Sell |
-12,547
| Closed | -$143K | – | 10162 |
|
|
2018
Q4 | $137K | Buy |
+12,547
| New | +$132K | ﹤0.01% | 8052 |
|
|
2018
Q3 | – | Sell |
-31,353
| Closed | -$378K | – | 10541 |
|
|
2018
Q2 | $413K | Buy |
+31,353
| New | +$375K | ﹤0.01% | 7190 |
|
|
2017
Q1 | – | Sell |
-39,074
| Closed | -$289K | – | 10291 |
|
|
2016
Q4 | $289K | Buy |
+39,074
| New | +$281K | ﹤0.01% | 8050 |
|
|
2016
Q3 | – | Sell |
-31,052
| Closed | -$147K | – | 9248 |
|
|
2016
Q2 | $139K | Buy |
+31,052
| New | +$117K | ﹤0.01% | 7864 |
|
|
2015
Q3 | – | Sell |
-13,622
| Closed | -$98.5K | – | 10390 |
|
|
2015
Q2 | $112K | Buy |
+13,622
| New | +$108K | ﹤0.01% | 9632 |
|
|
2015
Q1 | – | Sell |
-42,659
| Closed | -$333K | – | 10095 |
|
|
2014
Q4 | $291K | Sell |
42,659
-2,260
| -5% | -$11.9K | ﹤0.01% | 8190 |
|
|
2014
Q3 | $202K | Buy |
44,919
+3,668
| +9% | +$19.4K | ﹤0.01% | 8663 |
|
|
2014
Q2 | $241K | Sell |
41,251
-643
| -2% | -$3.61K | ﹤0.01% | 8750 |
|
|
2014
Q1 | $278K | Sell |
41,894
-127,436
| -75% | -$885K | ﹤0.01% | 7704 |
|
|
2013
Q4 | $980K | Buy |
+169,330
| New | +$873K | ﹤0.01% | 5551 |
|
Other funds holding CCXI
Susquehanna International Group's CCXI Position: Q4 2022 in Review
Susquehanna International Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 62,963 shares — an estimated $3.25M sold.
Susquehanna International Group first reported a position in CCXI in Q4 2013 and held it in 24 quarters. The position peaked at $13.5M in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Susquehanna International Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Susquehanna International Group sold 62,963 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3.25M.
- Susquehanna International Group first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 24 quarters.
- Susquehanna International Group's ChemoCentryx, Inc. position peaked at $13.5M in Q2 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.